Maria R. Parkhurst

13.6k total citations · 5 hit papers
64 papers, 9.2k citations indexed

About

Maria R. Parkhurst is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Maria R. Parkhurst has authored 64 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Immunology, 44 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Maria R. Parkhurst's work include Immunotherapy and Immune Responses (50 papers), CAR-T cell therapy research (41 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Maria R. Parkhurst is often cited by papers focused on Immunotherapy and Immune Responses (50 papers), CAR-T cell therapy research (41 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Maria R. Parkhurst collaborates with scholars based in United States, Israel and Malaysia. Maria R. Parkhurst's co-authors include Steven A. Rosenberg, Paul F. Robbins, Mark E. Dudley, Nicholas P. Restifo, Alena Gros, Eric Tran, John P. Riley, Todd D. Prickett, Jared J. Gartner and John R. Wunderlich and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Maria R. Parkhurst

62 papers receiving 9.0k citations

Hit Papers

Immunologic and therapeutic evaluation of a synthetic pep... 1998 2026 2007 2016 1998 2014 2010 2016 2020 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
    1998 1.5k citations Steven A. Rosenberg, Nicholas P. Restifo et al. profile →
  2. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
    2014 1.3k citations Eric Tran, Simon Turcotte et al. Science profile →
  3. T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
    2010 791 citations Maria R. Parkhurst, James C. Yang et al. Molecular Therapy profile →
  4. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
    2016 597 citations Alena Gros, Maria R. Parkhurst et al. profile →
  5. mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
    2020 313 citations Gal Cafri, Jared J. Gartner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria R. Parkhurst United States 37 7.1k 6.0k 3.1k 1.1k 772 64 9.2k
Karine Breckpot Belgium 54 4.5k 0.6× 3.2k 0.5× 3.4k 1.1× 1.1k 1.0× 1.0k 1.3× 170 7.6k
Zhili Zheng United States 43 5.8k 0.8× 7.8k 1.3× 3.1k 1.0× 2.5k 2.3× 595 0.8× 68 10.0k
Eric Tran United States 30 4.9k 0.7× 6.0k 1.0× 1.7k 0.5× 690 0.6× 556 0.7× 54 7.3k
Jared J. Gartner United States 30 4.3k 0.6× 5.2k 0.9× 2.3k 0.7× 733 0.7× 628 0.8× 60 6.9k
Thorbald van Hall Netherlands 47 6.1k 0.8× 4.1k 0.7× 2.5k 0.8× 480 0.4× 546 0.7× 127 8.1k
Mona El‐Gamil United States 29 4.4k 0.6× 4.0k 0.7× 2.8k 0.9× 938 0.9× 481 0.6× 41 6.6k
Winfried S. Wels Germany 51 5.0k 0.7× 5.9k 1.0× 2.7k 0.9× 1.6k 1.4× 1.7k 2.2× 176 8.9k
Hyam I. Levitsky United States 39 6.7k 0.9× 3.7k 0.6× 1.9k 0.6× 902 0.8× 392 0.5× 65 8.3k
Daniel J. Powell United States 49 5.3k 0.7× 6.8k 1.1× 2.0k 0.6× 1.5k 1.4× 417 0.5× 118 8.8k
Alena Gros Spain 28 3.6k 0.5× 4.3k 0.7× 1.5k 0.5× 939 0.9× 378 0.5× 54 5.6k

Countries citing papers authored by Maria R. Parkhurst

Since Specialization
Citations

This map shows the geographic impact of Maria R. Parkhurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria R. Parkhurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria R. Parkhurst more than expected).

Fields of papers citing papers by Maria R. Parkhurst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria R. Parkhurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria R. Parkhurst. The network helps show where Maria R. Parkhurst may publish in the future.

Co-authorship network of co-authors of Maria R. Parkhurst

This figure shows the co-authorship network connecting the top 25 collaborators of Maria R. Parkhurst. A scholar is included among the top collaborators of Maria R. Parkhurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria R. Parkhurst. Maria R. Parkhurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nah, Shirley, A. Gustafson, Billel Gasmi, et al.. (2025). Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous Melanoma. Journal of Clinical Oncology. 43(22). 2479–2489.
2.
Rosenberg, Steven A., Maria R. Parkhurst, & Paul F. Robbins. (2023). Adoptive cell transfer immunotherapy for patients with solid epithelial cancers. Cancer Cell. 41(4). 646–648. 17 indexed citations
3.
Hanada, Ken‐ichi, Chihao Zhao, Jared J. Gartner, et al.. (2022). A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers. Cancer Cell. 40(5). 479–493.e6. 90 indexed citations
4.
Levin, Noam, Biman C. Paria, Nolan R. Vale, et al.. (2021). Identification and Validation of T-cell Receptors Targeting RAS Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy. Clinical Cancer Research. 27(18). 5084–5095. 29 indexed citations
5.
Lo, Winifred, Maria R. Parkhurst, Paul F. Robbins, et al.. (2019). Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer. Cancer Immunology Research. 7(4). 534–543. 105 indexed citations
6.
Deniger, Drew C., Anna Pasetto, Eric Tran, et al.. (2016). Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System. Molecular Therapy. 24(6). 1078–1089. 54 indexed citations
7.
Prickett, Todd D., Jessica S. Crystal, Cyrille J. Cohen, et al.. (2016). Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens. Cancer Immunology Research. 4(8). 669–678. 88 indexed citations
8.
Pasetto, Anna, Alena Gros, Paul F. Robbins, et al.. (2016). Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor. Cancer Immunology Research. 4(9). 734–743. 148 indexed citations
9.
Parkhurst, Maria R., Alena Gros, Anna Pasetto, et al.. (2016). Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression. Clinical Cancer Research. 23(10). 2491–2505. 136 indexed citations
10.
Tran, Eric, Simon Turcotte, Alena Gros, et al.. (2014). Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer. Science. 344(6184). 641–645. 1278 indexed citations breakdown →
11.
Rosati, Shannon F., Maria R. Parkhurst, Young Ki Hong, et al.. (2014). A Novel Murine T-Cell Receptor Targeting NY-ESO-1. Journal of Immunotherapy. 37(3). 135–146. 23 indexed citations
12.
Parkhurst, Maria R., John P. Riley, Mark E. Dudley, & Steven A. Rosenberg. (2011). Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression. Clinical Cancer Research. 17(19). 6287–6297. 367 indexed citations
13.
Chinnasamy, Nachimuthu, Jennifer A. Wargo, Zhiya Yu, et al.. (2010). A TCR Targeting the HLA-A*0201–Restricted Epitope of MAGE-A3 Recognizes Multiple Epitopes of the MAGE-A Antigen Superfamily in Several Types of Cancer. The Journal of Immunology. 186(2). 685–696. 130 indexed citations
14.
Parkhurst, Maria R., John P. Riley, Zhiya Yu, et al.. (2008). Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells. Clinical Cancer Research. 15(1). 169–180. 89 indexed citations
15.
Lotem, Michal, Yangbing Zhao, John P. Riley, et al.. (2006). Presentation of Tumor Antigens by Dendritic Cells Genetically Modified With Viral and Nonviral Vectors. Journal of Immunotherapy. 29(6). 616–627. 24 indexed citations
16.
Parkhurst, Maria R., John P. Riley, Takehito Igarashi, et al.. (2004). Immunization of Patients with the hTERT:540-548 Peptide Induces Peptide-Reactive T Lymphocytes That Do Not Recognize Tumors Endogenously Expressing Telomerase. Clinical Cancer Research. 10(14). 4688–4698. 91 indexed citations
17.
Parkhurst, Maria R., John P. Riley, Paul F. Robbins, & Steven A. Rosenberg. (2004). Induction of CD4+ Th1 Lymphocytes That Recognize Known and Novel Class II MHC Restricted Epitopes from the Melanoma Antigen gp100 by Stimulation with Recombinant Protein. Journal of Immunotherapy. 27(2). 79–91. 10 indexed citations
18.
19.
Clay, Timothy M., Mary Custer, Mark D. McKee, et al.. (1999). Changes in the Fine Specificity of gp100(209–217)-Reactive T Cells in Patients Following Vaccination with a Peptide Modified at an HLA-A2.1 Anchor Residue. The Journal of Immunology. 162(3). 1749–1755. 88 indexed citations
20.
Saltzman, W. Mark, et al.. (1992). Three‐dimensional Cell Cultures Mimic Tissuesa. Annals of the New York Academy of Sciences. 665(1). 259–273. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karine Breckpot Breakdown of academic impact, for papers by Zhili Zheng Breakdown of academic impact, for papers by Eric Tran Breakdown of academic impact, for papers by Jared J. Gartner Breakdown of academic impact, for papers by Thorbald van Hall Breakdown of academic impact, for papers by Mona El‐Gamil Breakdown of academic impact, for papers by Winfried S. Wels Breakdown of academic impact, for papers by Hyam I. Levitsky Breakdown of academic impact, for papers by Daniel J. Powell Breakdown of academic impact, for papers by Alena Gros
Rankless by CCL
2026